Open
SectorHealthcare
3.25 -0.31
24h
Min
3.11
Max
3.28
Income | -24M -154K |
---|---|
Sales | -32M 19M |
P/E Sector Avg | 5.768 35.739 |
Profit margin | -0.825 |
Employees | 119 |
EBITDA | -24M -939K |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +53.43% upside |
Next Earnings | 6 lis 2025 |
---|
Market Cap | 156M 533M |
---|---|
Previous open | 3.56 |
Previous close | 3.25 |
By Acuity
50%
50%
149 / 371 Ranking in Healthcare
By Trading Central
Confidence
Strong Bullish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 5.14 USD 53.43%
High 7 USD
Low 3.5 USD
Based on 8 Wall Street analysts offering 12 month price targets forCytomX Therapeutics Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$